The connected patient in decentralized clinical trials

In this third installment in our three-part series on decentralized clinical trials, learn about the need for – and development of – novel digital biomarkers and the broader concept of digital health, which will truly have a revolutionary effect on clinical research. In addition, explore how the digitalization of the supply chain – and the use of cold chain logistics – is making this possible, enabling transformational impacts for pharmaceutical companies and patients.